Review



probiotic blend  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    ATCC probiotic blend
    Probiotic Blend, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 746 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/probiotic blend/product/ATCC
    Average 96 stars, based on 746 article reviews
    probiotic blend - by Bioz Stars, 2026-03
    96/100 stars

    Images



    Similar Products

    probiotic blend  (ATCC)
    96
    ATCC probiotic blend
    Probiotic Blend, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/probiotic blend/product/ATCC
    Average 96 stars, based on 1 article reviews
    probiotic blend - by Bioz Stars, 2026-03
    96/100 stars
    		  Buy from Supplier
    probiotic made of a blend of limosilactobacillus reuteri ncimb 30242  (NCIMB Ltd)
    90
    NCIMB Ltd probiotic made of a blend of limosilactobacillus reuteri ncimb 30242
    ( A ) Metabolic syndrome and microbiota: systematic reviews and meta-analyses. ( B ) Probiotics and metabolic syndrome: randomized and non-randomized clinical trials. ( C ) Probiotics and metabolic syndrome: systematic reviews and meta-analyses.
    Probiotic Made Of A Blend Of Limosilactobacillus Reuteri Ncimb 30242, supplied by NCIMB Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/probiotic made of a blend of limosilactobacillus reuteri ncimb 30242/product/NCIMB Ltd
    Average 90 stars, based on 1 article reviews
    probiotic made of a blend of limosilactobacillus reuteri ncimb 30242 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    probiotic blend (pb)  (AB Biotics)
    90
    AB Biotics probiotic blend (pb)
    ( A ) Metabolic syndrome and microbiota: systematic reviews and meta-analyses. ( B ) Probiotics and metabolic syndrome: randomized and non-randomized clinical trials. ( C ) Probiotics and metabolic syndrome: systematic reviews and meta-analyses.
    Probiotic Blend (Pb), supplied by AB Biotics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/probiotic blend (pb)/product/AB Biotics
    Average 90 stars, based on 1 article reviews
    probiotic blend (pb) - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    similac ® probiotic tri-blend  (Abbott Laboratories)
    90
    Abbott Laboratories similac ® probiotic tri-blend
    Characterization of prophylactic <t> probiotic </t> use in US NICUs.
    Similac ® Probiotic Tri Blend, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/similac ® probiotic tri-blend/product/Abbott Laboratories
    Average 90 stars, based on 1 article reviews
    similac ® probiotic tri-blend - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    probiotic blend of l.plantarum and p.acidilactici ab21  (AB Biotics)
    90
    AB Biotics probiotic blend of l.plantarum and p.acidilactici ab21
    Characterization of prophylactic <t> probiotic </t> use in US NICUs.
    Probiotic Blend Of L.Plantarum And P.Acidilactici Ab21, supplied by AB Biotics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/probiotic blend of l.plantarum and p.acidilactici ab21/product/AB Biotics
    Average 90 stars, based on 1 article reviews
    probiotic blend of l.plantarum and p.acidilactici ab21 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    microencapsulated probiotic blend l. plantarum ncimb 8826  (NCIMB Ltd)
    90
    NCIMB Ltd microencapsulated probiotic blend l. plantarum ncimb 8826
    Recent double-blinded randomized controlled clinical trials on <t> probiotic </t> therapies for obesity and aging
    Microencapsulated Probiotic Blend L. Plantarum Ncimb 8826, supplied by NCIMB Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/microencapsulated probiotic blend l. plantarum ncimb 8826/product/NCIMB Ltd
    Average 90 stars, based on 1 article reviews
    microencapsulated probiotic blend l. plantarum ncimb 8826 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    proprietary probiotic sample blends  (Biomatrix Inc)
    90
    Biomatrix Inc proprietary probiotic sample blends
    Recent double-blinded randomized controlled clinical trials on <t> probiotic </t> therapies for obesity and aging
    Proprietary Probiotic Sample Blends, supplied by Biomatrix Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/proprietary probiotic sample blends/product/Biomatrix Inc
    Average 90 stars, based on 1 article reviews
    proprietary probiotic sample blends - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    commercial probiotic blends  (Biomatrix Inc)
    90
    Biomatrix Inc commercial probiotic blends
    Recent double-blinded randomized controlled clinical trials on <t> probiotic </t> therapies for obesity and aging
    Commercial Probiotic Blends, supplied by Biomatrix Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/commercial probiotic blends/product/Biomatrix Inc
    Average 90 stars, based on 1 article reviews
    commercial probiotic blends - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    commercial probiotic blends containing clay-based binder with bacillus subtilis  (Biomatrix Inc)
    90
    Biomatrix Inc commercial probiotic blends containing clay-based binder with bacillus subtilis
    Recent double-blinded randomized controlled clinical trials on <t> probiotic </t> therapies for obesity and aging
    Commercial Probiotic Blends Containing Clay Based Binder With Bacillus Subtilis, supplied by Biomatrix Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/commercial probiotic blends containing clay-based binder with bacillus subtilis/product/Biomatrix Inc
    Average 90 stars, based on 1 article reviews
    commercial probiotic blends containing clay-based binder with bacillus subtilis - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    ( A ) Metabolic syndrome and microbiota: systematic reviews and meta-analyses. ( B ) Probiotics and metabolic syndrome: randomized and non-randomized clinical trials. ( C ) Probiotics and metabolic syndrome: systematic reviews and meta-analyses.

    Journal: Metabolites

    Article Title: Therapeutic Strategies to Modulate Gut Microbial Health: Approaches for Chronic Metabolic Disorder Management

    doi: 10.3390/metabo15020127

    Figure Lengend Snippet: ( A ) Metabolic syndrome and microbiota: systematic reviews and meta-analyses. ( B ) Probiotics and metabolic syndrome: randomized and non-randomized clinical trials. ( C ) Probiotics and metabolic syndrome: systematic reviews and meta-analyses.

    Article Snippet: Wastyk HC et al. [ ] , Randomized controlled trial , 39 adults with elevated Met-S parameters, 23 assigned to the intervention arm, 16 to placebo , Probiotic made of a blend of Limosilactobacillus reuteri NCIMB 30242, Lactiplantibacillus plantarum UALp-05TM, and Bifidobacterium animalis subsp. lactis B420TM , 18 weeks , Evaluate the effects of the use of probiotics by themselves to lower Met-S parameters , No significant effects on any of the parameters considered. Data possibly explained by there being responders and non-responders. , Hypothesis of some individuals responding to treatments with probiotics while others being resistant to it could be considered. , High.

    Techniques: Probiotics, Clinical Proteomics, Expressing, Activation Assay, Transplantation Assay, Permeability, Concentration Assay, Control

    ( A ) Diabetes and microbiota: randomized and non-randomized controlled trials. ( B ) Diabetes and microbiota: systematic reviews and meta-analyses. ( C ) Probiotics and diabetes: randomized and non-randomized clinical trials. ( D ) Probiotics and diabetes: systematic reviews and meta-analyses.

    Journal: Metabolites

    Article Title: Therapeutic Strategies to Modulate Gut Microbial Health: Approaches for Chronic Metabolic Disorder Management

    doi: 10.3390/metabo15020127

    Figure Lengend Snippet: ( A ) Diabetes and microbiota: randomized and non-randomized controlled trials. ( B ) Diabetes and microbiota: systematic reviews and meta-analyses. ( C ) Probiotics and diabetes: randomized and non-randomized clinical trials. ( D ) Probiotics and diabetes: systematic reviews and meta-analyses.

    Article Snippet: Wastyk HC et al. [ ] , Randomized controlled trial , 39 adults with elevated Met-S parameters, 23 assigned to the intervention arm, 16 to placebo , Probiotic made of a blend of Limosilactobacillus reuteri NCIMB 30242, Lactiplantibacillus plantarum UALp-05TM, and Bifidobacterium animalis subsp. lactis B420TM , 18 weeks , Evaluate the effects of the use of probiotics by themselves to lower Met-S parameters , No significant effects on any of the parameters considered. Data possibly explained by there being responders and non-responders. , Hypothesis of some individuals responding to treatments with probiotics while others being resistant to it could be considered. , High.

    Techniques: Probiotics, Clinical Proteomics, Sequencing, Control, Expressing, Immunohistochemical staining, Bacteria, Next-Generation Sequencing, Software, Gas Chromatography, Mass Spectrometry, Functional Assay, Comparison, Concentration Assay, Permeability, Produced

    ( A ) Obesity and microbiota: randomized and non-randomized controlled trials. ( B ) Probiotics and obesity: randomized and non-randomized clinical trials. ( C ) Probiotics and obesity: systematic reviews and meta-analyses.

    Journal: Metabolites

    Article Title: Therapeutic Strategies to Modulate Gut Microbial Health: Approaches for Chronic Metabolic Disorder Management

    doi: 10.3390/metabo15020127

    Figure Lengend Snippet: ( A ) Obesity and microbiota: randomized and non-randomized controlled trials. ( B ) Probiotics and obesity: randomized and non-randomized clinical trials. ( C ) Probiotics and obesity: systematic reviews and meta-analyses.

    Article Snippet: Wastyk HC et al. [ ] , Randomized controlled trial , 39 adults with elevated Met-S parameters, 23 assigned to the intervention arm, 16 to placebo , Probiotic made of a blend of Limosilactobacillus reuteri NCIMB 30242, Lactiplantibacillus plantarum UALp-05TM, and Bifidobacterium animalis subsp. lactis B420TM , 18 weeks , Evaluate the effects of the use of probiotics by themselves to lower Met-S parameters , No significant effects on any of the parameters considered. Data possibly explained by there being responders and non-responders. , Hypothesis of some individuals responding to treatments with probiotics while others being resistant to it could be considered. , High.

    Techniques: Probiotics, Clinical Proteomics, Sequencing, Preserving, Control, Real-time Polymerase Chain Reaction, Gas Chromatography, Bacteria, Capsules, Concentration Assay, Formulation, Computed Tomography, Gene Expression, Expressing, Activity Assay

    ( A ) Hyperhomocysteinemia and microbiota: systematic reviews and meta-analysis. ( B ) Probiotics and hyperhomocysteinemia: randomized and non-randomized clinical trials.

    Journal: Metabolites

    Article Title: Therapeutic Strategies to Modulate Gut Microbial Health: Approaches for Chronic Metabolic Disorder Management

    doi: 10.3390/metabo15020127

    Figure Lengend Snippet: ( A ) Hyperhomocysteinemia and microbiota: systematic reviews and meta-analysis. ( B ) Probiotics and hyperhomocysteinemia: randomized and non-randomized clinical trials.

    Article Snippet: Wastyk HC et al. [ ] , Randomized controlled trial , 39 adults with elevated Met-S parameters, 23 assigned to the intervention arm, 16 to placebo , Probiotic made of a blend of Limosilactobacillus reuteri NCIMB 30242, Lactiplantibacillus plantarum UALp-05TM, and Bifidobacterium animalis subsp. lactis B420TM , 18 weeks , Evaluate the effects of the use of probiotics by themselves to lower Met-S parameters , No significant effects on any of the parameters considered. Data possibly explained by there being responders and non-responders. , Hypothesis of some individuals responding to treatments with probiotics while others being resistant to it could be considered. , High.

    Techniques: Probiotics, Clinical Proteomics, Concentration Assay

    ( A ) Dyslipidemia and microbiota: randomized and non-randomized controlled trials. ( B ) Dyslipidemia and microbiota: systematic reviews and meta-analyses. ( C ) Probiotics and dyslipidemia: randomized and non-randomized clinical trials. ( D ) Probiotics and dyslipidemia: systematic reviews and meta-analyses.

    Journal: Metabolites

    Article Title: Therapeutic Strategies to Modulate Gut Microbial Health: Approaches for Chronic Metabolic Disorder Management

    doi: 10.3390/metabo15020127

    Figure Lengend Snippet: ( A ) Dyslipidemia and microbiota: randomized and non-randomized controlled trials. ( B ) Dyslipidemia and microbiota: systematic reviews and meta-analyses. ( C ) Probiotics and dyslipidemia: randomized and non-randomized clinical trials. ( D ) Probiotics and dyslipidemia: systematic reviews and meta-analyses.

    Article Snippet: Wastyk HC et al. [ ] , Randomized controlled trial , 39 adults with elevated Met-S parameters, 23 assigned to the intervention arm, 16 to placebo , Probiotic made of a blend of Limosilactobacillus reuteri NCIMB 30242, Lactiplantibacillus plantarum UALp-05TM, and Bifidobacterium animalis subsp. lactis B420TM , 18 weeks , Evaluate the effects of the use of probiotics by themselves to lower Met-S parameters , No significant effects on any of the parameters considered. Data possibly explained by there being responders and non-responders. , Hypothesis of some individuals responding to treatments with probiotics while others being resistant to it could be considered. , High.

    Techniques: Probiotics, Clinical Proteomics, Bacteria, Control, Activity Assay, Concentration Assay

    ( A ) Sarcopenia and microbiota: randomized and non-randomized controlled trials. ( B ) Probiotics and sarcopenia: randomized and non-randomized clinical trials. The upward arrow (↑) denotes an increase, whereas the downward arrow (↓) denotes a decrease.

    Journal: Metabolites

    Article Title: Therapeutic Strategies to Modulate Gut Microbial Health: Approaches for Chronic Metabolic Disorder Management

    doi: 10.3390/metabo15020127

    Figure Lengend Snippet: ( A ) Sarcopenia and microbiota: randomized and non-randomized controlled trials. ( B ) Probiotics and sarcopenia: randomized and non-randomized clinical trials. The upward arrow (↑) denotes an increase, whereas the downward arrow (↓) denotes a decrease.

    Article Snippet: Wastyk HC et al. [ ] , Randomized controlled trial , 39 adults with elevated Met-S parameters, 23 assigned to the intervention arm, 16 to placebo , Probiotic made of a blend of Limosilactobacillus reuteri NCIMB 30242, Lactiplantibacillus plantarum UALp-05TM, and Bifidobacterium animalis subsp. lactis B420TM , 18 weeks , Evaluate the effects of the use of probiotics by themselves to lower Met-S parameters , No significant effects on any of the parameters considered. Data possibly explained by there being responders and non-responders. , Hypothesis of some individuals responding to treatments with probiotics while others being resistant to it could be considered. , High.

    Techniques: Probiotics, Clinical Proteomics, Shotgun Sequencing, Sequencing, Fat

    Characterization of prophylactic probiotic use in US NICUs.

    Journal: Journal of Perinatology

    Article Title: Contemporary use of prophylactic probiotics in NICUs in the United States: a survey update

    doi: 10.1038/s41372-024-01952-0

    Figure Lengend Snippet: Characterization of prophylactic probiotic use in US NICUs.

    Article Snippet: Further, an FDA warning to Abbott Laboratories on October 24, 2023 led to discontinued sales of Similac ® Probiotic Tri-Blend.

    Techniques: Probiotics

    Characterization of opinions towards AAP probiotic statement and an FDA-approved probiotic formulation.

    Journal: Journal of Perinatology

    Article Title: Contemporary use of prophylactic probiotics in NICUs in the United States: a survey update

    doi: 10.1038/s41372-024-01952-0

    Figure Lengend Snippet: Characterization of opinions towards AAP probiotic statement and an FDA-approved probiotic formulation.

    Article Snippet: Further, an FDA warning to Abbott Laboratories on October 24, 2023 led to discontinued sales of Similac ® Probiotic Tri-Blend.

    Techniques: Formulation, Probiotics

    Recent double-blinded randomized controlled clinical trials on probiotic therapies for obesity and aging

    Journal: Microbiome Research Reports

    Article Title: Probiotics, prebiotics, synbiotics and other microbiome-based innovative therapeutics to mitigate obesity and enhance longevity via the gut-brain axis

    doi: 10.20517/mrr.2024.05

    Figure Lengend Snippet: Recent double-blinded randomized controlled clinical trials on probiotic therapies for obesity and aging

    Article Snippet: A microencapsulated probiotic blend ( L. rhamnosus NCIMB 6375, L. plantarum NCIMB 8826 and L. fermentum NCIMB 5221) was also studied for its effects on HFD-induced MetS hamsters and resulted in favorable alterations to the gut microbiota through decreasing the F/B ratio [ ] .

    Techniques: Clinical Proteomics, Reflux